CDC data show alcohol use during pregnancy is rising again

CDC data show alcohol use during pregnancy is rising again

Alcohol use during pregnancy is rising again

New CDC data show that alcohol use during pregnancy rose from 13.5% in 2021 to 15% in 2024, marking a reversal of earlier progress and signaling that prevention remains an open challenge for public health authorities and healthcare providers.

The data underscore a critical point for healthcare administrators and clinical informatics teams: alcohol use during pregnancy is not a historical problem or a solved public health issue. Instead, it represents an ongoing clinical and epidemiological concern that requires sustained attention in routine care workflows. The 2024 prevalence figure—15 percent of pregnant individuals—reflects a meaningful segment of the patient population and suggests that current prevention and screening strategies may not be reaching or engaging all women at risk.

For B2B healthcare organizations, these statistics carry workflow implications. They reinforce the case for embedding alcohol screening into standard obstetric intake protocols, electronic health record (EHR) templates, and primary care workflows for women of reproductive age. The data also suggest that screening alone is insufficient; they point to a need for evidence-based counseling, referral pathways, and care coordination infrastructure to support women who do report alcohol use.

IntelligenceRegulatory Impact▾

CDC decisions frame this story. Regulatory relevance is medium for pregnancy, with alcohol most exposed. Track designations, submission types, and label or guidance shifts that could move timelines.

CDC guidance remains clear on zero alcohol use

The CDC recommends that women of reproductive age avoid alcohol entirely when they are pregnant, attempting to become pregnant, or could become pregnant. This guidance has been in place since February 2016 and reflects the regulatory and clinical consensus on safe alcohol use in pregnancy.

No amount of alcohol consumption has been determined to be safe during pregnancy. This absolute threshold—zero tolerance—sets a clear clinical boundary and removes ambiguity from counseling conversations. Unlike some health behaviors where moderation is acceptable, alcohol use during pregnancy carries no identified safe threshold, making the recommendation categorical rather than dose-dependent.

For clinical teams and health systems, this clarity is operationally important. It means screening workflows do not need to quantify "safe" versus "unsafe" consumption; any reported use during pregnancy or in women who could become pregnant warrants documentation, counseling, and follow-up.

IntelligenceMarket Signals▾

Commercial pull is medium and investment relevance low for pregnancy. Expect implications for pricing, access, and launch sequencing.

Fetal alcohol spectrum disorders remain the core clinical risk

Alcohol use during pregnancy can cause fetal alcohol spectrum disorders (FASDs), which are lifelong behavioral, intellectual, and physical disabilities. FASDs represent the clinical consequence that underpins all CDC and medical guidance on alcohol avoidance in pregnancy.

From a healthcare system perspective, FASD represents a lifelong care burden. Affected individuals require ongoing developmental monitoring, educational support, behavioral health services, and coordination across pediatric, neurodevelopmental, and social services. Prevention through screening and counseling during pregnancy is therefore a high-leverage intervention point—it addresses the root cause before harm occurs, rather than managing the consequences across decades of care.

IntelligenceStrategic Takeaways▾

Alcohol use during pregnancy rose from 13.5% in 2021 to 15% in 2024 , indicating a reversal of prior progress and sustained public health concern. The CDC recommends zero alcohol use for women who are pregnant, attempting to become pregnant, or could become pregnant. Alcohol use during pregnancy can cause fetal alcohol spectrum disorders (FASDs), lifelong behavioral, intellectual, and physical disabilities.

B2B implications for screening, counseling, and workflow design

The rising prevalence of alcohol use during pregnancy reinforces the case for systematic screening in obstetric and primary care settings. Healthcare systems and EHR vendors can expect continued emphasis on integrating alcohol screening into standard intake workflows, particularly for women of reproductive age and those planning pregnancy.

Medical assistants and nursing staff play a role in screening workflows, with documentation in the EHR and referral to the clinician for counseling or further assessment. The rising prevalence of alcohol use during pregnancy suggests ongoing demand for screening tools, patient engagement platforms, and care coordination infrastructure to support evidence-based counseling and referral pathways.

IntelligenceEvidence Quality▾

Grounded in 2 regulatory sources and 1 peer-reviewed source.

Key Takeaways

• Alcohol use during pregnancy rose from 13.5% in 2021 to 15% in 2024, indicating a reversal of prior progress and sustained public health concern.
• The CDC recommends zero alcohol use for women who are pregnant, attempting to become pregnant, or could become pregnant.
• Alcohol use during pregnancy can cause fetal alcohol spectrum disorders (FASDs), lifelong behavioral, intellectual, and physical disabilities.
• Rising prevalence reinforces demand for systematic screening workflows in obstetric and primary care settings.
• Healthcare organizations can expect sustained interest in EHR-integrated screening tools, patient education, and care coordination infrastructure.

Frequently Asked Questions